Phase II study of palliative radiotherapy combined with Zoledronic Acid Hydrate for metastatic bone tumor from renal cell carcinoma
Phase 2
- Conditions
- Renal cancer
- Registration Number
- JPRN-UMIN000007836
- Lead Sponsor
- Shizuoka Cancer Center Japanese Radiation Oncology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Surgery is needed for bone metastasis 2)Hypercalcemia 3)Dental problem
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skeletal-related event
- Secondary Outcome Measures
Name Time Method